glp-1 drugs cancer may reduce the risk of progressing, study suggests New GLP-1 Guidelines for Type
Description
Additionally, DMS treatment led to a reduction in monocyte and macrophage populations while increasing the absolute number of ILC3s, thereby enhancing IL-22 production
WH, RS, RC, CL, RG, WT, JZ and QZ drafted and revised the manuscript
Doubt same outcome w sota
Kosei, T
Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, et al
